Elanco Animal Health Incorporated Common Stock (NY:ELAN)

22.67 +0.53 (+2.39%)

Delayed Quote Updated: 12:40 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Why Kindred Biosciences Stock Skyrocketed Today ↗

June 16, 2021

The pet therapeutics pioneer is being scooped up by a global animal health leader.

Via The Motley Fool

Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today ↗

June 16, 2021

Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) and Inhibikase Therapeutics, Inc. (NASDAQ: IKT)...

Via Benzinga

Mid-Day Market Update: Dow Falls 40 Points; Aprea Therapeutics Shares Surge ↗

June 16, 2021

Midway through trading Wednesday, the Dow traded down 0.12% to 34,259.48 while the NASDAQ rose 0.20% to 14,100.31. The S&P also fell, dropping 0.05% to 4,244.41. The U.S. has...

Via Benzinga

Topics Stocks

Elanco Is Looking To Challenge Zoetis, Will The $440 Million Kindred Buyout Help? ↗

June 16, 2021

Elanco Animal Health said Wednesday it would buy Kindred Biosciences for roughly $440 million, sending KIN stock soaring.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Mixed; Elanco Animal Health To Acquire Kindred Biosciences ↗

June 16, 2021

Following the market opening Wednesday, the Dow traded down 0.15% to 34,247.35 while the NASDAQ rose 0.36% to 14,123.49. The S&P also fell, dropping 0.01% to 4,246.07. The U.S...

Via Benzinga

Topics Stocks

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Kindred Biosciences Stock Jumps On $440M Elanco Animal Buyout Deal ↗

June 16, 2021

Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to acquire Kindred Biosciences Inc (NASDAQ: KIN) for $9.25 per share, or approximately $440 million...

Via Benzinga

Elanco Announces Agreement to Acquire Kindred Biosciences

June 16, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Animal Health's Debt Overview ↗

June 15, 2021

Over the past three months, shares of Elanco Animal Health (NYSE:ELAN) rose by 14.38%. Before we understand the importance of debt, let us look at how much debt Elanco...

Via Benzinga

Elanco Releases Environmental, Social and Governance (ESG) Summary

June 10, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Elanco To Exit Three Manufacturing Sites To Streamline Footprint ↗

June 09, 2021

Following the acquisition of Bayer Animal Health, Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to sell its sites in Shawnee, Kansas, and Speke,...

Via Benzinga

Elanco Announces Exit of Three Manufacturing Sites, Streamlining Footprint

June 09, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Announces Addition of Marcela A. Kirberger as General Counsel and Corporate Secretary

June 04, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Social Distancing Creates Pet-Buying Boom that Sends the Industry to New Heights

June 01, 2021

Via FinancialNewsMedia

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗

May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

Via Benzinga

Elanco to Participate in Upcoming Investor Conferences

May 20, 2021

From Elanco Animal Health Incorporated

Via Business Wire

The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics ↗

May 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...

Via Benzinga

Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios ↗

May 18, 2021

The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More ↗

May 15, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs. A couple of chief executive officers and...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021 ↗

May 11, 2021

Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year...

Via Benzinga

Elanco Launches Product for U.S. Poultry Producers, Providing a Flexible Option for Cocci Control

May 11, 2021

From Elanco Animal Health Incorporated

Via Business Wire

ELANCO ANIMAL HEALTH INC (ELAN) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

ELAN earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Elanco Shares Rise After Q1 Earnings Exceed Expectations, Raises FY21 Outlook ↗

May 07, 2021

Elanco Animal Health Inc (NYSE: ELAN) has reported Q1 EPS of $0.37 higher than $0.13 reported a year ago. It surpassed analysts' estimate of $0.23 and...

Via Benzinga

Elanco Animal Health Reports First Quarter 2021 Results

May 07, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Earnings Preview for Elanco Animal Health ↗

May 06, 2021

Elanco Animal Health (NYSE:ELAN) will be releasing its next round of earnings this Friday, May 07. For all of the relevant information, here is your guide for Friday's Q1 earnings...

Via Benzinga

Elanco Animal Health Introduces First Oral Flea and Tick Product for Cats, Credelio® CAT (lotilaner)

May 04, 2021

From Elanco Animal Health Incorporated

Via Business Wire

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

Earnings Scheduled For May 7, 2021 ↗

May 07, 2021

Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is...

Via Benzinga

A Product Recall Crashed Elanco's Stock. Is This a Buying Opportunity? ↗

April 27, 2021

Elanco's share price has come under pressure amid new concerns over a key product.

Via The Motley Fool

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.